AABB hosts biannual meetings that bring together representatives from the blood community with FDA and other relevant federal government agencies to exchange information on topics of mutual concern. Click on a meeting date below for summaries, attendance lists and other resources.
FDA Liaison Meeting - 5/16/19
FDA Liaison Meeting - 3/6/18
FDA Liaison Meeting - 1/31/17
FDA Liaison Meeting - 5/9/16
FDA Liaison Meeting - 9/21/15
FDA Liaison Meeting - 2/27/15
FDA Liaison Meeting - 5/16/14
FDA Liaison Meeting - 9/27/13
FDA Liaison Meeting - 5/2/13
FDA Liaison Meeting - 11/1/12
FDA Liaison Meeting - 4/12/12
FDA Liaison Meeting - 9/30/11
FDA Liaison Meeting - 3/30/11
FDA Liaison Meeting - 11/23/10
FDA Liaison Meeting - 1/7/10
REGULATORY UPDATE: FDA Expects IRA Final Guidance Before End of PHE
February 03, 2023
Peter Marks to Join Thursday Hot Topic Discussion on Individual Risk Assessment
February 01, 2023
REGULATORY UPDATE: FDA Releases 2023 Guidance Agenda
January 31, 2023